Table 2 Subjects’ characteristics in numeric variables and comparison results
Variables | All Subjects (n = 44) | No Conversion (n = 31) | Conversion (n = 13) | P—Value | |||
|---|---|---|---|---|---|---|---|
Mean | Std. Dev | Mean | Std. Dev | Mean | Std. Dev | ||
Independent Sample T-Test | |||||||
Age (years) | 49.57 (26–76) | 14.09 | 48.16 (26–76) | 15.42 | 52.92 (33–67) | 9.96 | 0.312 |
BMI | 25.31 (15.03–40.40) | 5.34 | 24.16 (15.03–40.40) | 5.16 | 28.05 (21.26–38.44) | 4.90 | 0.026** |
Hemoglobin Level (g/dL) | 12.93 (9.9–16.7) | 1.35 | 12.90 (9.9–16.7) | 1.48 | 12.99 (11.5–14.6) | 1.04 | 0.852 |
Leucocytes Count (× 109/L) | 8.66 (3.70–15.60) | 2.84 | 7.78 (3.70–13.20) | 2.16 | 10.75 (6.40–15.60) | 3.23 | 0.001** |
Indirect Bilirubin (mg/dL) | 0.46 (0.08–1.10) | 0.21 | 0.41 (0.1–0.7) | 0.17 | 0.59 (0.08–1.10) | 0.25 | 0.008** |
Mann Whitney U Test | |||||||
Neutrophil—Lymphocyte Ratio* | 3.34 (0.95–21.44) | 3.79 | 2.29 (0.95–8.06) | 1.25 | 5.85 (1.71–21.44) | 6.17 | 0.052 |
AST / SGOT* (U/L) | 20.57 (6–46) | 7.99 | 20.84 (6–46) | 8.50 | 19.92 (12–35) | 6.89 | 0.651 |
ALT / SGPT* (U/L) | 27.49 (11–96) | 20.09 | 28.31 (11.0–96.0) | 20.77 | 25.54 (12–76) | 19.03 | 0.303 |
Total Bilirubin* (mg/dL) | 0.81 (0.3–2.2) | 0.34 | 0.72 (0.3–1.2) | 0.26 | 1.02 (0.6–2.2) | 0.42 | 0.015** |
Direct Bilirubin* (mg/dL) | 0.36 (0.1–1.1) | 0.19 | 0.32 (0.1–0.7) | 0.18 | 0.43 (0.20–1.10) | 0.23 | 0.049** |
Adhesion | 0.000** | ||||||
Gall Bladder Stone Count | 0.853 | ||||||
Post-Surgery Hospitalization* (days) | 2.43 (2–5) | 0.73 | 2.10 (2–3) | 0.30 | 3.23 (2–5) | 0.83 | 0.000** |
Surgery Duration (minutes)* | 42.61 (20–75) | 38.87 (20–75) | 10.22 | 51.54 (30–70) | 10.87 | 0.001** | |
Chi Square Test | |||||||
Gender | 0.166 | ||||||
Cholecystitis Clinical Manifestation | 0.201 | ||||||
USG Cholecystitis Findings | 0.000** | ||||||
Microscopic Findings | 0.000** | ||||||